RARE Ultragenyx Pharmaceutical Inc.
Nasdaq · SEC CIK 1515673 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $3.95M 25 sales by 9 insiders
- Filings on record
- 172 since 2021-07-08, latest 2026-09-15 18:57
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Horn Howard | CFO | — | $1.33M |
| KAKKIS EMIL D | Pres, CEO, Dir | — | $1.24M |
| Parschauer Karah Herdman | EVP, CLO | — | $487.9K |
| Harris Erik | EVP, Chief Commercial Off | — | $240.3K |
| Pinion John Richard | See Remarks | — | $228.7K |
| Crombez Eric | EVP, Chief Medical Off | — | $168.8K |
| SULIMAN SHEHNAAZ | Dir | — | $144.2K |
| Huizenga Theodore Alan | SVP, CAO | — | $59.8K |
| Sanders Corazon (Corsee) D. | Dir | — | $50.1K |
| Ray Amrit | Dir | — | — |
Transactions 235
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-03 | 2022-03-01 | RARE | Parschauer Karah Herdman | EVP, CLO | A - Grant | $0.00 | +14.0K | 39.6K | +55% | $0 |
| D | 2022-03-03 | 2022-03-01 | RARE | Parschauer Karah Herdman | EVP, CLO | S - Sale | $66.62 | -2,886 | 25.5K | -10% | -$192.3K |
| D | 2022-03-03 | 2022-03-01 | RARE | Kassberg Thomas Richard | EVP, CBO | S - Sale | $66.62 | -2,374 | 213.8K | -1% | -$158.2K |
| D | 2022-03-03 | 2022-03-01 | RARE | Kassberg Thomas Richard | EVP, CBO | A - Grant | $0.00 | +14.0K | 227.8K | +7% | $0 |
| D | 2022-03-03 | 2022-03-01 | RARE | Huang Dennis Karl | See Remarks | S - Sale | $66.62 | -3,234 | 36.9K | -8% | -$215.4K |
| D | 2022-03-03 | 2022-03-01 | RARE | Huang Dennis Karl | See Remarks | A - Grant | $0.00 | +14.0K | 51.0K | +38% | $0 |
| DM | 2022-03-03 | 2022-03-01+ | RARE | Dier Mardi | CFO, EVP | S - Sale | $65.71 | -954 | 38.2K | -2% | -$62.7K |
| D | 2022-03-03 | 2022-03-01 | RARE | Dier Mardi | CFO, EVP | A - Grant | $0.00 | +14.0K | 52.2K | +37% | $0 |
| D | 2022-03-03 | 2022-03-01 | RARE | Bedrosian Camille L | EVP, Chief Medical Off | S - Sale | $66.62 | -2,821 | 33.9K | -8% | -$187.9K |
| D | 2022-03-03 | 2022-03-01 | RARE | Bedrosian Camille L | EVP, Chief Medical Off | A - Grant | $0.00 | +14.0K | 47.9K | +41% | $0 |
| D | 2022-03-03 | 2022-03-01 | RARE | KAKKIS EMIL D | Pres, CEO, Dir | F - Tax | $67.37 | -12.2K | 582.2K | -2% | -$819.4K |
| D | 2022-03-03 | 2022-03-01 | RARE | KAKKIS EMIL D | Pres, CEO, Dir | A - Grant | $0.00 | +52.0K | 634.2K | +9% | $0 |
| D | 2022-03-03 | 2022-03-01 | RARE | Huizenga Theodore Alan | SVP, CAO | A - Grant | $0.00 | +3,710 | 17.0K | +28% | $0 |
| D | 2022-03-03 | 2022-03-01 | RARE | Huizenga Theodore Alan | SVP, CAO | S - Sale | $66.62 | -843 | 13.2K | -6% | -$56.2K |
| D | 2022-03-03 | 2022-03-01 | RARE | Harris Erik | EVP, Chief Commercial Off | S - Sale | $66.62 | -2,713 | 22.3K | -11% | -$180.7K |
| D | 2022-03-03 | 2022-03-01 | RARE | Harris Erik | EVP, Chief Commercial Off | A - Grant | $0.00 | +14.0K | 36.3K | +63% | $0 |
| D | 2022-03-03 | 2022-03-01 | RARE | Pinion John Richard | See Remarks | A - Grant | $0.00 | +14.0K | 59.3K | +31% | $0 |
| D | 2022-03-03 | 2022-03-01 | RARE | Pinion John Richard | See Remarks | S - Sale | $66.62 | -4,498 | 45.3K | -9% | -$299.7K |
| 2022-02-01 | 2022-01-30 | RARE | Bedrosian Camille L | EVP, Chief Medical Off | S - Sale | $66.30 | -1,657 | 36.8K | -4% | -$109.9K | |
| 2021-10-18 | 2021-10-14 | RARE | Kassberg Thomas Richard | EVP, CBO | S - Sale | $81.14 | -286 | 216.3K | -0.1% | -$23.2K | |
| 2021-10-18 | 2021-10-14 | RARE | Huizenga Theodore Alan | SVP, CAO | S - Sale | $81.14 | -140 | 14.1K | -1.0% | -$11.4K | |
| 2021-10-18 | 2021-09-13 | RARE | Huizenga Theodore Alan | SVP, CAO | G - Gift | $0.00 | -819 | 14.2K | -5% | $0 | |
| 2021-10-18 | 2021-10-14 | RARE | Harris Erik | EVP, Chief Commercial Off | S - Sale | $81.14 | -303 | 25.0K | -1% | -$24.6K | |
| 2021-10-18 | 2021-10-14 | RARE | Pinion John Richard | See Remarks | S - Sale | $81.14 | -358 | 49.8K | -0.7% | -$29.0K | |
| 2021-10-18 | 2021-10-14 | RARE | Huang Dennis Karl | EVP, Chief Tech Ops Off | S - Sale | $81.14 | -358 | 40.1K | -0.9% | -$29.0K | |
| 2021-10-18 | 2021-10-14 | RARE | KAKKIS EMIL D | Pres, CEO, Dir | F - Tax | $81.00 | -853 | 594.3K | -0.1% | -$69.1K | |
| 2021-10-18 | 2021-10-14 | RARE | Bedrosian Camille L | EVP, Chief Medical Off | S - Sale | $81.14 | -359 | 38.4K | -0.9% | -$29.1K | |
| 2021-10-18 | 2021-10-14 | RARE | Parschauer Karah Herdman | EVP, GC | S - Sale | $81.14 | -310 | 28.4K | -1% | -$25.2K | |
| M | 2021-10-14 | 2021-10-12+ | RARE | Dier Mardi | CFO, EVP | S - Sale | $82.00 | -6,738 | 38.8K | -15% | -$552.5K |
| D | 2021-10-01 | 2021-09-30 | RARE | Kassberg Thomas Richard | EVP, CBO | M - OptEx | $0.31 | +109.7K | 216.6K | +103% | +$34.0K |
| D | 2021-09-09 | 2021-09-08 | RARE | Parschauer Karah Herdman | EVP, GC | S - Sale+OE | $100.65 | -7,336 | 28.7K | -20% | -$738.4K |
| D | 2021-09-09 | 2021-09-08 | RARE | Parschauer Karah Herdman | EVP, GC | M - OptEx | $54.50 | +7,336 | 36.0K | +26% | +$399.8K |
| DM | 2021-09-02 | 2021-09-01+ | RARE | Bedrosian Camille L | EVP, Chief Medical Off | M - OptEx | $55.00 | +5,000 | 41.3K | +14% | +$275.0K |
| DM | 2021-09-02 | 2021-09-01+ | RARE | Bedrosian Camille L | EVP, Chief Medical Off | S - Sale+OE | $100.11 | -5,000 | 38.8K | -11% | -$500.5K |
| 2021-07-08 | 2021-07-06 | RARE | Harris Erik | EVP, Chief Commercial Off | S - Sale | $91.53 | -375 | 25.3K | -1% | -$34.3K |
Purchase Sale Sale after option exercise All abbreviations